Zdrowie i gospodarka · 06/12/2017

FDA Extends Comment Period for Review of Existing Regulatory and Information Collection Requirements

The Food and Drug Administration (FDA) is extending the comment period for its September 8, 2017, Federal Register notice, which requested comments and information from interested parties to identify existing regulations and paperwork requirements that could be modified or repealed to reduce burden while achieving public health goals and statutory obligations.